Valeant Pharmaceuticals International, Inc. (VRX)


NYSE - NYSE Real Time Price. Currency in USD
27.72+0.87 (+3.24%)
At close: 4:01 PM EDT
People also watch:
AGNBIIBGILDREGNFIT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open26.56
Prev Close26.85
Bid27.73 x 3000
Ask27.79 x 100
Day's Range26.46 - 27.84
52wk Range18.55 - 206.51
1y Target EstN/A
Market Cap9.63B
P/E Ratio (ttm)-9.44
Beta-1.12
Volume12,035,052
Avg Vol (3m)25,943,548
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.comyesterday

    Investing for the Next 100 Years

    After a decade of working with family offices of all sizes, types, and means, Ned Dane, head of the OppenheimerFunds’ Private Client Group, says that in the end their goals are all the same: to generate income for families for hundreds of years. One long-term investment that Dane offers his clients is catastrophe bonds, which are a fixed-income form of reinsurance, traditionally the way the insurance industry spreads its bets to other insurance companies.

  • Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest
    Investor's Business Dailyyesterday

    Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest

    Amgen and Biogen could square off to acquire muscle biologist Cytokinetics, while many players look at Adamas Pharmaceuticals.

  • Is Valeant Pharmaceuticals Playing With Fire?
    Motley Foolyesterday

    Is Valeant Pharmaceuticals Playing With Fire?

    Valeant's management team may not have learned its lesson after all.